Detalles de la búsqueda
1.
Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT).
BMC Med
; 21(1): 72, 2023 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36829154
2.
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.
BMC Cancer
; 21(1): 341, 2021 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33789616
3.
Subgroup analysis by prior anti-VEGF or anti-EGFR target therapy in FRESCO, a randomized, double-blind, Phase III trial.
Future Oncol
; 17(11): 1339-1350, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325251
4.
Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma.
Cancer Sci
; 111(2): 637-646, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31677335
5.
SBF2-AS1: An oncogenic lncRNA in small-cell lung cancer.
J Cell Biochem
; 120(9): 15422-15428, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31050364
6.
CircRNA circ_0026344 as a prognostic biomarker suppresses colorectal cancer progression via microRNA-21 and microRNA-31.
Biochem Biophys Res Commun
; 503(2): 870-875, 2018 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29928882
7.
Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering miR-4302.
Biochem Biophys Res Commun
; 500(4): 846-851, 2018 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29698681
8.
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial.
JAMA
; 319(24): 2486-2496, 2018 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29946728
9.
c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.
Tumour Biol
; 37(3): 4007-15, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26482621
10.
[Methylation of ER and ER gene and its significance in primary and relapsed/metastatic lesions of breast cancer].
Zhonghua Zhong Liu Za Zhi
; 36(2): 128-31, 2014 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-24796462
11.
Comparison of dose-dense ABVD and standard ABVD in the treatment of early unfavorable and advanced Hodgkin's lymphoma: a retrospective analysis.
J Huazhong Univ Sci Technolog Med Sci
; 34(2): 260-264, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24710942
12.
MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.
Med Sci Monit
; 18(8): BR299-308, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22847191
13.
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations.
JTO Clin Res Rep
; 3(10): 100407, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36217329
14.
Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study.
Ther Adv Med Oncol
; 14: 17588359221133546, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36339926
15.
Efficacy and safety of margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging study.
Transl Breast Cancer Res
; 3: 31, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751523
16.
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3).
Cancer Commun (Lond)
; 42(12): 1314-1330, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36336841
17.
Erratum to: c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.
Tumour Biol
; 37(4): 5653, 2016 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26662571
18.
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study.
Lancet Respir Med
; 9(10): 1154-1164, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34166627
19.
Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer.
Onco Targets Ther
; 14: 4439-4450, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34408440
20.
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study.
EClinicalMedicine
; 42: 101187, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34841235